(Q37068632)

18 August 2017

1 reference

title

The aging hypertensive heart: a brief update (English)

1 reference

18 August 2017

2

Edward D Frohlich

1 reference

18 August 2017

Dinko Susic

1

1 reference

PubMed ID

18223542

18 August 2017

language of work or name

1 reference

1 February 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

2

1 reference

18 August 2017

104-110

1 reference

Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Senescent heart compared with pressure overload-induced hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Heart failure with normal systolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Arterial stiffness and wave reflection in hypertension: pathophysiologic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Ventricular arterial stiffening: integrating the pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Connective tissue and the heart. Functional significance and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Fibrosis and ischemia: the real risks in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Cardiac interstitium in health and disease: the fibrillar collagen network

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Matrix metalloproteinases: regulation and dysregulation in the failing heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Molecular mechanisms of myocardial remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

IGF-1 modulation of rat cardiac fibroblast behavior and gene expression is age-dependent

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Heart failure in older adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

New molecular mechanism in diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Response of the coronary vasculature to myocardial hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Small artery remodeling in hypertension: can it be corrected?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Systolic and diastolic heart failure: different phenotypes of the same disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Treatment of isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Blood pressure and ageing

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Diastolic heart failure in the elderly and the potential role of aldosterone antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

The role of sodium in hypertension is more complex than simply elevating arterial pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

The dietary sodium-blood pressure plot "stiffens".

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Endothelium, aging, and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Ageing as a determinant of renal and vascular disease: role of endothelial factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Angiotensin II receptor antagonist improves age-related endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Arginine nutrition and cardiovascular function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Role of glycation in aging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Crosslink breakers: a new approach to cardiovascular therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1091

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1091

1 reference

18 August 2017

1 reference

PubMed ID

18223542